The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lol,
I didn't see it had made the website :) ;)
Sorry gix didn’t realise that was the article you found ,but you do find a lot of stuff I can’t keep keep up !
Nice to see the article/advert made By-Healths website.
This is the relevant section that I posted on the 17th regarding wstc and new health claim regulations.
"To be marketed in China, vitamin and dietary supplement products must currently fit into health function measures. But local authorities in China are planning new regulations that allow the assessment of new functions.
Building on its years of research, BYHEALTH hopes to take advantage of this opportunity and register new categories of dietary supplement properties, Liang says. For example, the company is working with the Institute of Chinese Materia Medica at China Academy of Chinese Medical Sciences to study the effects of water-soluble tomato concentrate on the properties of blood in mice."
https://www.nature.com/articles/d42473-023-00164-y
A small piece about wste . But all good advertising . http://www.by-health.com/en/aboutus/news/4715/
We all have to respect that nothing can be disclosed to an individual that hasn't been notified to everyone. The desire for certainty over funding has hung over us for the whole of this year to date. I agree with you that the lack of news has to mean that funding is not under threat. It's as tough a time for us as I can remember, alleviated by the information on the By Health studies and submissions. China isn't in the best of economic times right now, but By Health seem able to keep growing.
The longer the silence from the company the more it makes you think they have found the money for payment to DSM , it could only come from income as any other way the market would have to be informed . I’m taking that a s a good sign ,it does seem strange that so much potential news from the interims and funding update has not appeared !
Perhaps someone who is on good terms with IF could give him a ring and get some clarity
Ff+ is not part of the AA agreement , whatever is going on we won’t know until the interims in December so no point in stressing about it now .
More linked to DSM income maybe
https://postimg.cc/k6sWtwzv
Don’t think you can read much into those order numbers , they have never indicated the true income received !
Looks like they have fallen off a cliff in the last 3 months if your number of 800 is correct for June?
Jan 3,208
Feb 3,115
March 3,170
April 2,839
May 2,078
June ?,??? (800)
Somehow I can't see sales falling that quick.
Perhaps Cbec are taking all stock ! Just a thought .
Numbers seem a bit strange as they were over 3000 at the start of the year.
Delta FF+ delta order number an all time low at less than 800.
W-?
Https://www.chinadaily.com.cn/a/202306/19/WS64906f59a310bf8a75d6ab99.html
May well be
"BY-HEALTH (300146) answered investors' concerns on the investor relations platform on May 17."
Investor: According to previous news reports, BY-HEALTH was preparing to promote Qingluosu products in 2016, and published some related articles every once in a while. May I ask why the company has not launched related products for so many years.
BY-HEALTH Board Secretary: Hello investors! The company has done relevant research and development and product reserves, and will launch new products in due course according to industry policies and the application and approval of new functions of health food. Thanks for attention.
https://stock-stockstar-com.translate.goog/RB2023051700026559.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
Everyone is assuming that all 8 studies are required for By-Healths regulatory submissions to SAMR. I don't believe that to be the case.
In total they have completed 8 trials, 6 clinical studies and 2 animal studies. SAMR have been involved in carrying out the scoping and testing. Hopefully the final approval is now a case of the new health claim process being agreed and published by SAMR and then the main board to give BH the final stamp of approval to start the 5 year period.
Thanks Gixer that makes the process a bit clearer, as it seems the animal testing is the last submission in the process to SAMR and the mouse trial has just been completed we might not be that far away (wishful thinking) Here’s hoping for a better week ,.
Sphinx, Bellow is just my opinion based on the evidence/articles that have been found.
"cause of the long delay"
"A claim beyond SAMR’s list is considered “new,” and, thus, not permissible. SAMR’s new draft rules provide more clarification to help guide industry when applying for the use of new functional claims for health foods. "
https://www.khlaw.com/insights/health-foods-china-new-rules-approving-functional-claims?language_content_entity=en
By-Health is seeking to establish a new permitted health function claim. This new claim is not allowed under the list as it is and SAMR have only issued the draft rules on how to apply for a new health function claim. Once the new regulations are in place By-Health can then submit to SAMR for the health function claim "for foods such as Fruitflow that can demonstrate an anti-platelet effect, addressing the aberrant blood clots which can lead to heart attacks and strokes."
Once SAMR have accepted By-Healths new health function claim then only By-Health can use it for five years during the monitoring period.
Aug 19, 2022
"we believe that companies could apply for the new health function claims in the near future."
https://www.cirs-group.com/en/food/products-with-the-new-health-function-claims-are-being-possible-in-china
Gix good recap , I notice this paragraph from your finds,"..............................................”Notably, SAMR also created a five-year monitoring period of the new claim, during which the company obtaining the approval of the claim is obligated to collect a range of data, e.g., sales numbers, consumer feedback, etc., and submit annual reports to SAMR for review. During these five years, the new claim is proprietary to the company, and others may not use it. After the end of the monitoring period, if no issues are observed, SAMR will add the new claim to the approved list of claims for health foods. Through such listing, anyone can use the new claim on their health foods.[3]”. What do you or anyone,make of this ,, it seems to me that SAMR work with the company to obtain the new claim but there seems to be the need for 5 years collaboration to achieve this ,in whichever case we could be in the 5th year ! Could this be the cause of the long delay ?
"By-Health continues to work on an extensive regulatory submission to the Chinese State Administration
for Market Regulation (SAMR) for Fruitflow, seeking to establish a new permitted health "FUNCTION CLAIM" for
foods such as Fruitflow that can demonstrate an anti-platelet effect, addressing the aberrant blood clots
which can lead to heart attacks and strokes."
https://www.provexis.com/wp-content/uploads/2022/12/Provexis_plc_30-Sep-22_interims_30-Dec-22.pdf
"To be marketed in China, vitamin and dietary supplement products must currently fit into health "FUNCTION" measures. But local authorities in China are planning new regulations that allow the assessment of new "FUNCTIONS"."
https://www.nature.com/articles/d42473-023-00164-y
"Health Foods in China: New Rules Approving "FUNCTIONAL CLAIMS""
https://www.khlaw.com/insights/health-foods-china-new-rules-approving-functional-claims?language_content_entity=en
I hope that makes it clearer.
I do not think a mice study will take more than 7years. It must be something else, which is holding back. Hope something good not bad.
The mice study must be the 1 animal study that we were waiting for , can we move forward now please .